Today: 7 February 2026
Subscribe
Browse Category

NYSE:LLY News 16 September 2025 - 24 November 2025

Eli Lilly (LLY) Stock Today, November 24, 2025: Trillion‑Dollar Milestone, $1,300 Price Target and New Weight‑Loss Shot Data

Eli Lilly (LLY) Stock Today, November 24, 2025: Trillion‑Dollar Milestone, $1,300 Price Target and New Weight‑Loss Shot Data

Eli Lilly and Company (NYSE: LLY) remains one of the most closely watched stocks on Wall Street today as it trades just below the historic $1 trillion valuation it briefly reached on Friday, while fresh analyst upgrades, new obesity‑drug data and a major setback for rival Novo Nordisk’s Alzheimer’s program dominate the news cycle. Reuters+1 Key takeaways for LLY on 24 November 2025 Eli Lilly stock price today: still trading like a tech high‑flyer As of around late morning U.S. time on Monday, November 24, 2025, Eli Lilly shares are trading near $1,069.56, up about $9.86 on the session, a
24 November 2025
···
Eli Lilly (LLY) Stock Today, November 23, 2025: Trillion‑Dollar Milestone, GLP‑1 Price War and Fresh Institutional Buying

Eli Lilly (LLY) Stock Today, November 23, 2025: Trillion‑Dollar Milestone, GLP‑1 Price War and Fresh Institutional Buying

Eli Lilly’s stock is entering the new week as one of the most closely watched names on Wall Street. As of this weekend (Sunday, November 23, 2025), LLY is trading near $1,060 per share, valuing the company at roughly $1 trillion, after becoming the first drugmaker ever to join the trillion‑dollar market‑cap club. Reuters At the same time, new headlines today highlight rising institutional ownership, aggressive analyst upgrades, and an emerging GLP‑1 price war that could reshape the economics of the obesity drug market Eli Lilly currently dominates. 1. LLY stock snapshot after the $1 trillion milestone On November 21,
23 November 2025
·····
Luxury Boom vs. Fed Gloom: European Markets Whipsaw (Sept 23–24, 2025)

5 Stocks You Need to Buy Now (November 4, 2025) – Tech, Energy, Biotech & More

Key Takeaways (November 4, 2025) <br> Table: Key Metrics for Top 5 Stocks (Nov 4, 2025) Company (Ticker) Price (Nov 4, 2025) Market Cap Trailing P/E Forward P/E Dividend Yield Amazon.com (AMZN) ~$254morningstar.com $2.60 Tmacrotrends.net ~34×finance.yahoo.com ~29×finance.yahoo.com N/A (growth) JPMorgan Chase (JPM) ~$309marketbeat.com $850 Bmarketbeat.com 15.3×marketbeat.com ~17× (est.) 1.9%marketbeat.com Eli Lilly (LLY) ~$863investing.com $803 Bstockanalysis.com 53.6×finance.yahoo.com 27.2×finance.yahoo.com ~0.7%macrotrends.net Exxon Mobil (XOM) ~$114reuters.com $488 Bmacrotrends.net 15.8×finance.yahoo.com 15.0×finance.yahoo.com 3.6%marketbeat.com Alibaba Group (BABA) ~$168finance.yahoo.com ~$375 Bstockanalysis.com ~17×seekingalpha.com 9.8×nasdaq.com N/A (reinvesting) (Market caps in USD; P/E = price-to-earnings ratio; Forward P/E uses next 12-month earnings forecasts. Dividend yield bolded for income-generating stocks.) 1. Amazon (AMZN) – E-Commerce & Cloud
4 November 2025
·······
2025’s Best-Performing Stock Market Is Up 35% – Here’s What’s Driving the Rally

2025’s Best-Performing Stock Market Is Up 35% – Here’s What’s Driving the Rally

Best Stock Market Performance as of October 29, 2025 Global Markets Rally to New Highs Stock markets around the world are on fire heading into the final days of October 2025. Hong Kong’s Hang Seng Index – up about 34–35% so far this year – is the planet’s best-performing major index Advisorperspectives. After a brutal multi-year slump, Hong Kong’s market came roaring back thanks to ultra-cheap valuations and China’s post-pandemic stimulus. Investors flooded into undervalued Chinese tech and consumer stocks, driving a dramatic rebound. As a result, the Hang Seng has erased its losses from prior years and is flirting
29 October 2025
·······
Pharma Giants Converge in Frankfurt – Obesity Drug Boom & Tech Innovations Fuel $1.7 Trillion Industry Future

Pharma Giants Converge in Frankfurt – Obesity Drug Boom & Tech Innovations Fuel $1.7 Trillion Industry Future

Sources: CPHI Frankfurt event coveragecontractpharma.comgxpnews.net; GxP Newsgxpnews.netgxpnews.net; The Medicine Maker/Conexiantconexiant.comconexiant.com; GlobeNewswire (Hengdian/Apeloa)globenewswire.com; Evaluate Pharma forecastevaluate.comevaluate.com; Reutersreuters.com; TechStock² / TS2 Techts2.techts2.tech; TS2 Techts2.techts2.tech.
28 October 2025
·····
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Market News & Today’s Financial Outlook Stocks are starting today on cautiously optimistic footing. Futures were little changed this morning after a batch of earnings delivered both relief and warnings. Netflix shocked investors with a rare earnings miss, sending its stock down ~6–7% in pre-market tradingreuters.com. And chipmaker Texas Instruments sank nearly 9% after issuing a bleak sales forecast, which in turn dragged down other semiconductor namesreuters.com. Those disappointments put a slight chill on Nasdaq futures. “We’re at a bit of a point of indecision, where nobody feels particularly strongly about anything,” noted Michael Green of Simplify Asset Management, observing
22 October 2025
··············
Eli Lilly’s Weight-Loss Pill Sheds Pounds Fast—But Hits a Plateau: What New Trial Results Mean for the Obesity Drug Race

Eli Lilly’s Weight-Loss Pill Sheds Pounds Fast—But Hits a Plateau: What New Trial Results Mean for the Obesity Drug Race

Trial Results: Big Early Losses, Then Weight Loss Levels Off This highly anticipated trial put Lilly’s oral GLP-1 drug, orforglipron, to the test in a large group of adults struggling with obesity. The study enrolled 3,127 overweight or obese participants (none had diabetes, but all had weight-related health issues) and randomly assigned them to various daily doses of the pill or a placebo for 72 weeks reuters.com. The outcomes were encouraging yet mixed. Patients on the highest dose (36 mg daily) lost on average about 11–12% of their starting body weight by week 72 theguardian.com. In practical terms, that’s roughly
17 September 2025
··
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Richmond’s New Pharma Giant: Overview of Lilly’s $5B Factory Eli Lilly’s forthcoming Richmond-area factory is set to be one of the largest and most advanced pharmaceutical manufacturing sites in the world. At a cost of $5 billion, Lilly will construct a high-tech production campus in Goochland County’s West Creek Business Park, a site that had been prepped for a previous project and now deemed “the perfect spot” for fast construction Washingtonpost. The facility’s core mission: make more of the critical drug ingredients that Lilly usually sources overseas, right here on U.S. soil Washingtonpost Washingtonpost. Scale and Scope: The plant will
16 September 2025
·······
1 … 11 12 13

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:44 AM EST Tech Wreck Signals Market Reset February 7, 2026, 12:44 AM EST. The recent **tech sector sell-off** marks a significant **market reset**. Investors are reevaluating growth expectations amid rising interest rates and economic uncertainty. The sharp decline in major technology stocks has dragged broader indexes lower, reflecting a shift from speculative gains to cautious positioning. Analysts suggest this could realign valuations with fundamental earnings and signal a more selective investment environment ahead. Market participants are watching closely as volatility increases and liquidity conditions tighten. ARC Resources
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop